Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Gastrografin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
CRE-induced SBO
1 trial -
Gefitinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
Gemcitabine, cisplatin
The First People's Hospital of Lianyungang
Bladder Cancer
1 trial -
Gene detection of therapeutic drugs for chronic cardiovascular and cerebrovascular diseases
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypertension,Essential
1 trial -
Genotype detected through GenSeizer high-throughput gene capture technology
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non - Tuberculosis Mycobacteria Lung Disease
1 trial -
Glimepiride
Takeda
Type 2 Diabetes
1 trial -
Gluten Powder
Regeneron UK Limited
Celiac Disease
1 trial -
GnRH-a-1M
The First People's Hospital of Lianyungang
Adenomyosis of Uterus
1 trial -
Goji berry
United Therapeutics Europe Ltd
Age-Related Macular Degeneration
1 trial -
Goserelin 3.6 mg implant
Universal Integrated
Postpartum Depression
1 trial -
Group A
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Crohn Disease
1 trial -
Group A (clinical guideline+machine learning)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypertension
1 trial -
Group S: sugammadex injection
Hospital Authority, Hong Kong
Head and Neck Surgery
1 trial -
Guideline-directed medical therapy
The First People's Hospital of Lianyungang
Heart Failure With Reduced Ejection Fraction
1 trial -
HCQ/CQ and CAB combined treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Resistance, Disease
1 trial -
HIV self-testing among female sex workers
United Therapeutics Europe Ltd
Human Immunodeficiency Virus (HIV)
1 trial -
HellenCare
The First People's Hospital of Lianyungang
Alzheimer's Disease Dementia
1 trial -
Hetrombopag
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hematological Disease
1 trial -
High Dose GGQL Decoction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetes Mellitus, Type 2
1 trial -
High energy high protein peptide feed study
United Therapeutics Europe Ltd
Malnutrition
1 trial -
House dust mite
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Allergic Asthma
1 trial -
Huangjing Yangji Formula Granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sarcopenia
1 trial -
Huangqi Guizhi Wuwu decoction
The First People's Hospital of Lianyungang
Diabetic Nephropathies
1 trial -
Human Urinary Kallidinogenase
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Ischemic Stroke
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources